Sage Journals: Discover world-class research

Free access

Review article

First published 2017-7

Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer

FNU Asad ur Rahman, Saeed Ali, Muhammad Wasif Saif

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study

Tomomi Koike, Yasunori Kawaguchi, Mototsugu Shimokawa [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer

Satoshi Kobayashi, Taito Fukushima, Shun Tezuka [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)

Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)

Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025-04

Validation of a Prognostic Nomogram for Patients with Metastatic Pancreatic Cancer Treated with Nanoliposomal Irinotecan as Second-Line Therapy

Yu-Shin Hung, Tai-Jan Chiu, Yen-Yang Chen [...]

Cancer Control

Open access

Research article

First published 2022

A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma

Jung Won Chun, Sang Myung Woo, Sang Hyub Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium

Lise Verbruggen, Lisa Verheggen, Greetje Vanhoutte [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain

Rafael Álvarez-Gallego, Roberto Pazo-Cid, Borja López de San Vicente [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

A phase II study of liposomal irinotecan with 5-fluorouracil,leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

Francesca Simionato, Camilla Zecchetto, Valeria Merz [...]

Therapeutic Advances in Medical Oncology

Search results